E-LIB Suche - Ergebnisse für: van Esdonk, Michiel J

1

A phase 1 trial of AP30663, a KCa2 channel inhibitor in dev..:

Yfanti, Christina ; Vestbjerg, Birgitte ; van't Westende, Juliette...
British Journal of Clinical Pharmacology. 90 (2024) 4 - p. 1027-1035 , 2024

Link: https://doi.org/10.1111/..

2

Item response theory in early phase clinical trials: Utiliz..:

Otto, Marije E. ; Bergmann, Kirsten R. ; de Kam, Marieke L....
CPT: Pharmacometrics & Systems Pharmacology. 12 (2023) 10 - p. 1425-1436 , 2023

Link: https://doi.org/10.1002/..

3

First-in-human study to assess the pharmacokinetics, tolera..:

de Laat, Willem ; Pagan, Lisa ; Malcolm, R. Karl...
Drug Delivery. 30 (2023) 1 - p. , 2023

Link: https://doi.org/10.1080/..

4

Correction: Wind et al. Topical Bimiralisib Shows Meaningfu..:

Wind, Selinde S. ; Jansen, Manon A. A. ; Rijsbergen, Melanie...
Cancers. 15 (2023) 5 - p. 1485 , 2023

Link: https://doi.org/10.3390/..

5

First-in-human study to assess the pharmacokinetics, tolera..:

Willem de Laat ; Lisa Pagan ; R. Karl Malcolm...
https://www.tandfonline.com/doi/10.1080/10717544.2023.2180113. , 2023

Link: https://doi.org/10.1080/..

6

Impact of enantiomer-specific changes in pharmacokinetics b..:

Cloesmeijer, Michael E ; van Esdonk, Michiel J ; Lynn, Anne M...
10.1111/bcp.14547. , 2023

Link: http://hdl.handle.net/10..

7

First-in-human study to assess the pharmacokinetics, tolera..:

de Laat, Willem ; Pagan, Lisa ; Malcolm, R. Karl...
de Laat , W , Pagan , L , Malcolm , R K , Wiegerinck , M , Nickolson , V , Huisman , B , Stuurman , R , van Esdonk , M & Klarenbeek , N 2023 , ' First-in-human study to assess the pharmacokinetics, tolerability, and safety of single-dose oxybutynin hydrochloride administered via a microprocessor-controlled intravaginal ring ' , Drug Delivery , vol. 30 , no. 1 , 2180113 . https://doi.org/10.1080/10717544.2023.2180113. , 2023

Link: https://pure.qub.ac.uk/e..

8

Correction: Wind et al. Topical Bimiralisib Shows Meaningfu..:

Selinde S. Wind ; Manon A. A. Jansen ; Melanie Rijsbergen...
https://dx.doi.org/10.3390/cancers15051485. , 2023

Link: https://doi.org/10.3390/..

9

Correction:Topical Bimiralisib Shows Meaningful Cutaneous D..:

Wind, Selinde S ; Jansen, Manon A. A ; Rijsbergen, Melanie...
https://research.vumc.nl/en/publications/2c9ed4a0-c5fa-4d2a-a168-ec2af1d95948. , 2023

Link: https://research.vumc.nl..

10

Correction: Wind et al. Topical Bimiralisib Shows Meaningfu..:

Selinde S. Wind ; Manon A. A. Jansen ; Melanie Rijsbergen...
https://www.mdpi.com/2072-6694/15/5/1485. , 2023

Link: https://doi.org/10.3390/..

11

A phase 1 trial of AP30663, a KCa2 channel inhibitor in dev..:

Yfanti, Christina ; Vestbjerg, Birgitte ; van't Westende, Juliette...
https://research.vumc.nl/en/publications/333e2336-3df8-4544-931e-eb13509ae41e. , 2023

Link: https://research.vumc.nl..

12

Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels ..:

Wind, Selinde ; Jansen, Manon ; Rijsbergen, Melanie...
Cancers. 14 (2022) 6 - p. 1510 , 2022

Link: https://doi.org/10.3390/..

13

Dose escalations in phase I studies: Feasibility of interpr..:

Hassing, Gerardus J. ; van Esdonk, Michiel J. ; van Westen, Gerard J. P....
British Journal of Clinical Pharmacology. 88 (2022) 12 - p. 5412-5419 , 2022

Link: https://doi.org/10.1111/..

14

Effects of Mexiletine and Lacosamide on Nerve Excitability ..:

Ruijs, Titia Q. ; Koopmans, Ingrid W. ; de Kam, Marieke L....
Clinical Pharmacology & Therapeutics. 112 (2022) 5 - p. 1008-1019 , 2022

Link: https://doi.org/10.1002/..

15

Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels ..:

Wind, Selinde S ; Jansen, Manon A. A ; Rijsbergen, Melanie...
https://research.vumc.nl/en/publications/2df739fa-d9c6-4682-a9f8-51afcad585c5. , 2022

Link: https://research.vumc.nl..